News
)
12 October 2023
VIVEbiotech is participating in Innovative Therapies Days
VIVEbiotech is participating in Innovative Therapies Days, "an oasis of innovation 2.5 hours from Paris"!
Read more)
11 October 2023
VIVEbiotech participates one more year in the Cell & Gene Meeting on the Mesa
VIVEbiotech is participating once again in the Cell & Gene Meeting on the Mesa congress in California.
Read more)
9 October 2023
VIVEbiotech featured in an article in BioPharm International
VIVEbiotech has been featured in an article in BioPharm International
Read more)
28 September 2023
VIVEbiotech: A Lentiviral Vector Specialist Bridging the Gap Between R&D and Commercialisation
An article featured by Natalia Elizalde, Chief Business Development Officer at VIVEbiotech, has just been published by European Pharmaceutical Manufacturer.
Read more)
14 September 2023
The Medicine Maker publishes an opinion article after interviewing Natalia Elizalde
The Medicine Maker has published an opinion article after interviewing Natalia Elizalde, VIVEbiotech´s Chief Business Development Officer.
Read more)
24 August 2023
VIVEbiotech will lead a session with speakers from top international companies during upcoming Biospain
Biospain is a biotechnology congress organized by AseBio - Asociación Española de Empresas Biotecnológicas and is held every two years in a...
Read more)
14 August 2023
Contribution to an article defining the benefits of lentiviruses in BioPharm International
In a recent article in BioPharm International, Chris Spivey speaks about different types of viral vectors that are regularly used in gene therapy, each with...
Read more)
17 July 2023
VIVEbiotech participates in the XVI Annual Biotechnology Congress
Soledad Baños-Mateos, senior researcher of the Department of Technological Innovation of VIVEbiotech, has participated in the XVI Congreso Anual de Biotecnología (BAC Badajoz 2023)...
Read more)
11 July 2023
VIVEbiotech contributes to accelerate the development of muscular dystrophies through the European MAGIC project
VIVEbiotech is a CDMO GMP that develops and manufactures lentiviral vectors from early stage to commercial scale. It is currently working on more than 40 international...
Read more)
19 June 2023
VIVEbiotech interview on C> manufacturing trends at Drug Discovery World
VIVEbiotech participated in the ISCT, International Society for Cell & Gene Therapy´s (ISCT) Annual Meeting took place three weeks ago in beautiful Paris.
Read moreDestacadas
)
)
)
)
)
)
)
)
)
23 August 2024
)